The Current Ratio as of November 2024 (TTM) for CRISPR Therapeutics AG (CRSP) is 21.64

According to CRISPR Therapeutics AG’s latest financial reports and current stock price. The company's current Current Ratio is 21.64. This represents a change of 19.05% compared to the average of 18.18 of the last 4 quarters.

CRISPR Therapeutics AG (CRSP) Historical Current Ratio (quarterly & annually)

How has CRSP Current Ratio performed in the past?

The mean historical Current Ratio of CRISPR Therapeutics AG over the last ten years is 15.29. The current 21.64 Current Ratio has changed 14.06% with respect to the historical average. Over the past ten years (40 quarters), CRSP's Current Ratio was at its highest in in the June 2021 quarter at 26.23. The Current Ratio was at its lowest in in the March 2015 quarter at 0.

CRISPR Therapeutics AG (CRSP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of CRISPR Therapeutics AG Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CRISPR Therapeutics AG (CRSP) Average Current Ratio

How has CRSP Current Ratio performed in the past?

The current Current Ratio of CRISPR Therapeutics AG (CRSP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

CRISPR Therapeutics AG (CRSP) Current Ratio vs. Peers

How is CRSP’s Current Ratio compared to its peers?

CRISPR Therapeutics AG’s Current Ratio is greater than Beam Therapeutics Inc. (5.69), greater than Editas Medicine, Inc. (3.75), greater than Caribou Biosciences, Inc. (7.38), greater than Verve Therapeutics, Inc. (13.05), greater than Intellia Therapeutics, Inc. (6.73), greater than Fate Therapeutics, Inc. (8.29), greater than Regeneron Pharmaceuticals, Inc. (5.28), greater than Novo Nordisk A/S (0.94), greater than Sarepta Therapeutics, Inc. (3.84), greater than CohBar, Inc. (15.69), greater than Hepion Pharmaceuticals, Inc. (1.30), greater than Rain Therapeutics Inc. (5.58), greater than Krystal Biotech, Inc. (7.97), less than AVROBIO, Inc. (26.17),

Build a custom stock screener for CRISPR Therapeutics AG (CRSP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CRISPR Therapeutics AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CRISPR Therapeutics AG (CRSP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CRISPR Therapeutics AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.